Literature DB >> 23016637

Perspectives on brain-targeting drug delivery systems.

Liangran Guo1, Jinfeng Ren, Xinguo Jiang.   

Abstract

Due to the presence of the blood-brain barrier, there is limited drug access into the brain. In order to overcome this challenge, various strategies have been developed to enhance penetration of drugs into the brain. Of these, the most frequently used are pharmacological technologies or comparable methods being developed for brain-targeting drug delivery using receptor- or adsorptive- or transporter-mediated transcytosis and the nose-to-brain route. It goes without saying that exploration of Brain-targeting drug delivery systems has created another potential option for the treatment of central nervous system diseases. In addition to above methods, other technologies for brain-targeting drug delivery (e.g. chemical delivery systems, prodrugs, pharmacological disruption of the BBB and inhibition of drug efflux by P-glycoprotein) are also summarized in this review.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23016637     DOI: 10.2174/138920112803341770

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  12 in total

Review 1.  Systemic delivery to central nervous system by engineered PLGA nanoparticles.

Authors:  Qiang Cai; Long Wang; Gang Deng; Junhui Liu; Qianxue Chen; Zhibiao Chen
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 2.  Targeted delivery of nano-therapeutics for major disorders of the central nervous system.

Authors:  Huile Gao; Zhiqing Pang; Xinguo Jiang
Journal:  Pharm Res       Date:  2013-10       Impact factor: 4.200

Review 3.  Is there new hope for therapeutic matrix metalloproteinase inhibition?

Authors:  Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Nat Rev Drug Discov       Date:  2014-11-07       Impact factor: 84.694

Review 4.  Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders.

Authors:  Hema Kumari Alajangi; Mandeep Kaur; Akanksha Sharma; Sumedh Rana; Shipali Thakur; Mary Chatterjee; Neha Singla; Pradeep Kumar Jaiswal; Gurpal Singh; Ravi Pratap Barnwal
Journal:  Mol Brain       Date:  2022-06-01       Impact factor: 4.399

5.  Cellular uptake mechanism and therapeutic utility of a novel peptide in targeted-delivery of proteins into neuronal cells.

Authors:  Ailing Fu; Zizhen Zhao; Feiyan Gao; Miaomiao Zhang
Journal:  Pharm Res       Date:  2013-05-15       Impact factor: 4.200

Review 6.  Which drug or drug delivery system can change clinical practice for brain tumor therapy?

Authors:  Tali Siegal
Journal:  Neuro Oncol       Date:  2013-03-15       Impact factor: 12.300

Review 7.  Progress and perspectives on targeting nanoparticles for brain drug delivery.

Authors:  Huile Gao
Journal:  Acta Pharm Sin B       Date:  2016-06-14       Impact factor: 11.413

8.  Reducing the risk of healthcare-associated infections through Lean Six Sigma: The case of the medicine areas at the Federico II University Hospital in Naples (Italy).

Authors:  Giovanni Improta; Mario Cesarelli; Paolo Montuori; Liberatina Carmela Santillo; Maria Triassi
Journal:  J Eval Clin Pract       Date:  2017-11-03       Impact factor: 2.431

Review 9.  Liposome delivery systems for the treatment of Alzheimer's disease.

Authors:  Callum Ross; Mark Taylor; Nigel Fullwood; David Allsop
Journal:  Int J Nanomedicine       Date:  2018-12-12

Review 10.  Dendrimer-Based Drug Delivery Systems for Brain Targeting.

Authors:  Yuefei Zhu; Chunying Liu; Zhiqing Pang
Journal:  Biomolecules       Date:  2019-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.